本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Twist Bioscience Corp

29.52
-2.7700-8.58%
盘前29.00-0.5200-1.76%05:55 EDT
成交量:154.47万
成交额:4,666.09万
市值:17.69亿
市盈率:-9.10
高:32.63
开:32.44
低:29.45
收:32.29
数据加载中...
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/22

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/11/17

重要事件披露

Form 8-K - Current report
2023/09/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/04

重要事件披露

Form 8-K/A - Current report: [Amend]